Who invested in Tiburio Therapeutics?
Tiburio Therapeutics's investors include New Enterprise Associates, Alexandria Real Estate Equities, Longitude Capital and Lundbeckfonden Ventures.
United States · Series A startup
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$31Mraised across 1 round since 2019, from 1 source
Reported by FinSMEsSEC filing: $5.0M sold, first sale Dec 2018
Tiburio Therapeutics's investors include New Enterprise Associates, Alexandria Real Estate Equities, Longitude Capital and Lundbeckfonden Ventures.
Tiburio Therapeutics has raised $31M across 1 round since 2019.
Tiburio Therapeutics's most recent round was a Series A of $31M in Jan 2019.
Its most recent round, $31M in Jan 2019, is also its largest on record.
Tiburio Therapeutics's first round on record, in Jan 2019, was backed by New Enterprise Associates, Alexandria Real Estate Equities and Longitude Capital and 1 others.
Tiburio Therapeutics's latest named round is a Series A, in Jan 2019.
Tiburio Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.